- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
BrightGene Bio Medical Technology C (688166)
BrightGene Bio Medical Technology C stock price live, this page displays SS 688166 stock exchange data. View the 688166 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the BrightGene Bio Medical Technology C real time stock price chart below.
What Is the BrightGene Bio Medical Technology C Stock Price Today?
The BrightGene Bio Medical Technology C stock price today is 105.27.
What Is the Stock Symbol for BrightGene Bio Medical Technology C?
The stock symbol for BrightGene Bio Medical Technology C is ""688166.""
What Stock Exchange Does BrightGene Bio Medical Technology C Trade On?
BrightGene Bio Medical Technology C is listed and trades on the Shanghai stock exchange.
Is BrightGene Bio Medical Technology C a Good Stock to Buy?
Determining whether BrightGene Bio Medical Technology C—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 688166 quote. (ISIN: CNE100003PR1)
What Is the BrightGene Bio Medical Technology C Stock Price Today?
The BrightGene Bio Medical Technology C stock price today is 105.27.
What Is the Stock Symbol for BrightGene Bio Medical Technology C?
The stock symbol for BrightGene Bio Medical Technology C is ""688166.""
What Stock Exchange Does BrightGene Bio Medical Technology C Trade On?
BrightGene Bio Medical Technology C is listed and trades on the Shanghai stock exchange.
Is BrightGene Bio Medical Technology C a Good Stock to Buy?
Determining whether BrightGene Bio Medical Technology C—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 688166 quote. (ISIN: CNE100003PR1)
Shanghai
Currency in CNY
105.27
-4.23(-3.86%)
Delayed Data·
Fair Value
An estimate of a BrightGene's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
105.20
112.40
52 wk Range
22.82
122.59
688166 Scorecard
Full Analysis
Trading at a high earnings multiple
688166 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a BrightGene's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
105.20112.40
52 wk Range
22.82122.59
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.09%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.09%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
688166 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a BrightGene's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
38.00
Downside
-63.90%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Has maintained dividend payments for 6 consecutive years
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
BrightGene Bio Medical Technology C Company Profile
BrightGene Bio-Medical Technology Co., Ltd., a pharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products in China. The company offers Eribulin mesylate injection, Voriconazole for injection, Entecavir tablets, Oseltamivir phosphate capsule and dry suspension, Agatroban injection, Mikafungin sodium for injection, Fondaparinux sodium injection, and Caspofungin acetate for injection. It also provides antitumor, antibodies drug conjugate, anti-infection, angiography, gynecology, cardiovascular, cerebrovascular, iron supplement, digestion, and other APIs and intermediates. In addition, the company offers veterinary drugs. BrightGene Bio-Medical Technology Co., Ltd. was founded in 2001 and is based in Suzhou, China.
Compare 688166 to Peers and Sector
Metrics to compare | 688166 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship688166PeersSector | |
|---|---|---|---|---|
P/E Ratio | 335.0x | 31.3x | −0.5x | |
PEG Ratio | −11.56 | −0.42 | 0.00 | |
Price/Book | 18.5x | 3.1x | 2.6x | |
Price / LTM Sales | 38.8x | 4.6x | 3.3x | |
Upside (Analyst Target) | −65.3% | 22.4% | 38.7% | |
Fair Value Upside | Unlock | 6.8% | 5.0% | Unlock |
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 38.00
(-63.90% Downside)
Earnings
Latest Release
May 30, 2025
EPS / Forecast
0.03 / --
Revenue / Forecast
248.96M / --
FAQ
What Stock Exchange Does BrightGene Trade On?
BrightGene is listed and trades on the Shanghai Stock Exchange stock exchange.
What Is the Stock Symbol for BrightGene?
The stock symbol for BrightGene is "688166."
What Is the BrightGene Market Cap?
As of today, BrightGene market cap is 48.41B.
What Is BrightGene's Earnings Per Share (TTM)?
The BrightGene EPS (TTM) is 0.33.
When Is the Next BrightGene Earnings Date?
BrightGene will release its next earnings report on 28 Aug 2025.
From a Technical Analysis Perspective, Is 688166 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has BrightGene Stock Split?
BrightGene has split 0 times.
How Many Employees Does BrightGene Have?
BrightGene has 1151 employees.
What is the current trading status of BrightGene (688166)?
As of 27 Aug 2025, BrightGene (688166) is trading at a price of 105.27, with a previous close of 109.50. The stock has fluctuated within a day range of 105.20 to 112.40, while its 52-week range spans from 22.82 to 122.59.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.